Strategic partnership Sequenex recently partnered with MedTech Innovator, signaling credibility and access to a leading startup accelerator network. This presents a sales opportunity to co-sell or collaborate on accelerator-supported medtech projects and pilot programs.

NEX platform Launch of the NEX customizable software platform positions Sequenex to engage biosensor and BLE-connected medical device developers seeking accelerated time-to-market and regulatory-ready foundations. Target firms building connected devices may benefit from immediate platform adoption.

Regulatory readiness All software development operates under an ISO 13485 certified QMS, offering full traceability and regulatory compliance. This is a strong differentiator for medtech clients needing compliant solutions and can drive opportunities in FDA/CE-regulatory navigation and documentation services.

Medtech focus Specialization in CGM, wearables, biosensors, and connected medical devices aligns with growing demand for integrated software in digital health. There is potential to upsell dedicated engineering resources and end-to-end medtech software development to device manufacturers expanding product lines.

Growth signals Mid-market revenue range combined with a lean team (11-50 employees) suggests agility and cost-effective engagement for pilot projects, accelerators, or long-term outsourcing deals with mid-sized medtech companies seeking scalable software foundations.